Cargando…
Risk assessment model constructed by differentially expressed lncRNAs for the prognosis of glioma
A risk assessment model was constructed using differentially expressed long non-coding (lnc)RNAs for the prognosis of glioma. Transcriptome sequencing of the lncRNAs and mRNAs from glioma samples were obtained from the TCGA database. The samples were divided into bad and good prognosis groups based...
Autores principales: | Hu, Chenggong, Zhou, Yongfang, Liu, Chang, Kang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151882/ https://www.ncbi.nlm.nih.gov/pubmed/30106138 http://dx.doi.org/10.3892/or.2018.6639 |
Ejemplares similares
-
Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma
por: Huang, Qianrong, et al.
Publicado: (2023) -
Identification of cuproptosis‐related lncRNAs for prognosis and immunotherapy in glioma
por: Wang, Lin, et al.
Publicado: (2022) -
A risk assessment model for the prognosis of osteosarcoma utilizing differentially expressed lncRNAs
por: Sun, Kai, et al.
Publicado: (2019) -
Immune-Related LncRNAs to Construct a Prognosis Risk-Assessment Model for Gastric Cancer
por: Zhi, Shilin, et al.
Publicado: (2022) -
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)
por: Li, Sui, et al.
Publicado: (2022)